02.03.2020 23:48:00

Gilead Sciences, Inc. -- Moody's: Gilead's acquisition of Forty Seven reduces cash levels but expands oncology focus

Announcement: Moody's: Gilead's acquisition of Forty Seven reduces cash levels but expands oncology focus
Vollständigen Artikel bei Moodys lesen